SCHEMBL3752815

SCHEMBL3752815

O=C(O)c1ccc(-c2cccc(F)c2F)nc1Oc1ccccc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.40
HSD11B1 P28845 1/20 0.40
P2RY1 P47900 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
RBP4 P02753 1/20 0.37
CTSA P10619 1/20 0.37
RORC P51449 2/20 0.37
IDO1 P14902 1/20 0.37
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
TTR P02766 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
DHODH Q02127 1/20 0.36
PPARG P37231 1/20 0.36
TAS2R14 Q9NYV8 1/20 0.36
RXRA P19793 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3753505 0.89 ALDH1A1 (0.43) ALDH1A1HPGDKDM4ECTSAPDCD1
SCHEMBL3752315 0.87 MPL (0.40) ALDH1A1HPGDKDM4ECTSARORC
SCHEMBL3753803 0.85 ALDH1A1 (0.43) ALDH1A1HPGDKDM4ECTSAPDCD1
SCHEMBL3759586 0.85 HTT (0.47) ALDH1A1HPGDKDM4ECTSAPDCD1
SCHEMBL3755130 0.84 KMO (0.44) KMOALDH1A1HPGDKDM4ECTSA
SCHEMBL3747340 0.83 KDM4E (0.44) ALDH1A1HPGDKDM4EMRGPRX4
SCHEMBL3757716 0.82 EIF4E (0.39) ALDH1A1HPGDKDM4EPDCD1CD274
SCHEMBL3753385 0.81 HSD11B1 (0.41) HSD11B1P2RY1CTSAIDO1PDCD1
SCHEMBL3758381 0.81 MRGPRX4 (0.42) ALDH1A1HPGDKDM4EMRGPRX4
SCHEMBL3758001 0.79 PLAU (0.43) ALDH1A1HPGDKDM4EPDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF NAPRT, PNPO, FABP3 KMO 533/4885HSD11B1 1761/4885P2RY1 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.